Skip to main
POAI
POAI logo

POAI P/E Ratio

P/E Ratio as of Jun 13, 2025: -0.52

Average-0.5245
Median-0.5250
Minimum-0.5900
Maximum-0.4700
-0.52
Past Month+0.07 (11.86%)
The P/E ratio for POAI is -0.52 as of Jun 13, 2025. This represents a increase of 44.44% compared to its 12-month average P/E ratio of -0.36. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Predictive Oncology Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Predictive Oncology Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Predictive Oncology Inc to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

POAI P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$0.95-0.51
May 1, 2025$1.17-0.46
Apr 1, 2025$1.48-0.59
Mar 3, 2025$1.26-0.41
Feb 3, 2025$1.39-0.45
Jan 2, 2025$0.92-0.30

POAI End of Year P/E Ratio

DateP/E ratioChange
2025-0.52+92.59%
2024-0.27-61.97%
2023-0.71-13.41%
2022-0.82-69.17%
2021-2.66+885.19%
2020-0.27

FAQs About Predictive Oncology Inc (POAI) P/E ratio

The latest P/E ratio of POAI is -0.52, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Predictive Oncology Inc’s last 12-month average P/E ratio is -0.36, compared to its current P/E ratio of -0.52. This reflects a increase of 44.44%.

Predictive Oncology Inc’s current P/E ratio of -0.52 is higher than its last 12-month average P/E of -0.36. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Predictive Oncology Inc’s average P/E ratio over the last 3 years is -0.7. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Predictive Oncology Inc’s average P/E ratio over the last 5 years is -0.82. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Predictive Oncology Inc (POAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.